Osaic Holdings’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-30,300
Closed -$2K – 7714
2022
Q4
$2K Buy
30,300
+14,755
+95% +$1.87K ﹤0.01% 6768
2022
Q3
$2K Buy
15,545
+14,980
+2,651% +$3.16K ﹤0.01% 6907
2022
Q2
$0 Buy
+565
New +$146 ﹤0.01% 7770
2022
Q1
– Sell
-365
Closed -$1K – 7730
2021
Q4
$1K Buy
365
+75
+26% +$221 ﹤0.01% 7317
2021
Q3
$1K Hold
290
– – ﹤0.01% 7131
2021
Q2
$1K Hold
290
– – ﹤0.01% 6935
2021
Q1
$1K Hold
290
– – ﹤0.01% 6738
2020
Q4
$1K Hold
290
– – ﹤0.01% 6327
2020
Q3
$0 Hold
290
– – ﹤0.01% 6511
2020
Q2
$1K Hold
290
– – ﹤0.01% 6035
2020
Q1
$0 Buy
+290
New +$592 ﹤0.01% 6254

Other funds holding STAB

Osaic Holdings's STAB Position: Q1 2023 in Review

Osaic Holdings sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 30,300 shares — an estimated $2K sold.

Osaic Holdings first reported a position in STAB in Q1 2020 and held it in 11 quarters. The position peaked at $2K in Q4 2022. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.

  • Osaic Holdings reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Osaic Holdings sold 30,300 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $2K.
  • Osaic Holdings first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Osaic Holdings's Statera Biopharma, Inc. Common Stock position peaked at $2K in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.